Oluwole Abe, MD
Clinical Cardiac Electrophysiology · London, KYNPI 1841269834
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (35.9%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Pfizer at 37.7% of the total. Reporting peaked in 2019 at $3,453 and has fallen 55.3% since, to $1,544 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in KY, where the typical reported total is $16,637.
Across 221 payments — averaging $44.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$4K
- Abbott$3K
- Medtronic$1K
- Novartis$779
- E.r. Squibb & Sons, L.L.C.$521
- Merck$420
- plus $891 from 14 others
What the payments were for
- Consulting fees$5005%
- Speaking & faculty fees$2,62527%
- Travel & lodging$3,19832%
- Food & beverage$3,54236%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 78 | $3,717 |
| Abbott | 20 | $2,535 |
| Medtronic | 7 | $1,002 |
| Novartis | 43 | $779 |
| E.r. Squibb & Sons, L.L.C. | 3 | $521 |
| Merck | 26 | $420 |
| Sanofi-aventis U.S. LLC | 18 | $327 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $107 |
| Baxter Healthcare | 1 | $97 |
| Bayer | 4 | $70 |
| Biotronik Inc. | 1 | $58 |
| Boston Scientific | 3 | $50 |
| Kestra Medical Technology Services, Inc. | 2 | $50 |
| Edwards Lifesciences | 1 | $33 |
| Terumo Medical Corporation | 1 | $30 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $25 |
| Atricure, Inc. | 1 | $19 |
| Amgen | 1 | $12 |
| Altathera Pharmaceuticals LLC | 1 | $8 |
| Bardy Diagnostics, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ELIQUIS$3,125
- ENSITE PRECISION$1,493
- Micra$878
- AVEIR$703
- VYNDAQEL$101
How this compares
$9,865 in reported general payments places this provider in the 25th percentile of 57 clinical cardiac electrophysiology providers in Kentucky.
See all clinical cardiac electrophysiology providers in Kentucky →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 685 | $606,273 |
| MultaqDronedarone Hcl | 127 | $149,236 |
| JardianceEmpagliflozin | 189 | $146,479 |
| EntrestoSacubitril/Valsartan | 116 | $119,918 |
| FarxigaDapagliflozin Propanediol | 105 | $75,867 |
| XareltoRivaroxaban | 42 | $43,170 |
| Ranolazine ErRanolazine | 158 | $25,363 |
| CorlanorIvabradine Hcl | 11 | $12,985 |
| SotalolSotalol Hcl | 390 | $6,289 |
| Amiodarone Hcl | 251 | $3,129 |
| Metoprolol Succinate | 190 | $1,653 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 262 | $1,542 |
| Spironolactone | 456 | $1,141 |
| Digoxin | 56 | $931 |
| Midodrine Hcl | 12 | $895 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $3,717 | $606,273685 claims |
| Sanofi-aventis U.S. LLCMultaq | $327 | $149,236127 claims |
| NovartisEntresto | $779 | $119,918116 claims |
| AmgenCorlanor | $12 | $12,98511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 57 clinical cardiac electrophysiology providers in Kentucky.
Other clinical cardiac electrophysiology in London
- Johan AasboLexington$451K
- Rajdeep GaitondeLouisville$404K
- Jeffrey StidamLouisville$196K
- Gery TomassoniLexington$196K
- Kent MorrisLouisville$187K
- John LeeLexington$139K
- Joseph SouzaLexington$110K
- Kevin ParrottLouisville$60K
- Vedran OrucPaducah$56K
- Michael AntimisiarisPikeville$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.